1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow LucasBio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation LB-DTK-BKV, Standard-of-care - Hemorrhagic Cystitis | Phase 1 / Phase 2 | Not yet recruiting | LucasBio | 42 | 2026-09-01 | 2026-07-24 |
| Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. LB-DTK-MV - BKV Infection, EBV Infection | Phase 1 / Phase 2 | Recruiting | LucasBio | 27 | 2025-12-04 | 2026-06-26 |
| Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients LB-DTK-COV19 - COVID-19, COVID-19 (SARS-CoV-2 Infection) | Phase 1 | Active not recruiting | LucasBio | 1 | 2025-07-31 | 2026-08-26 |
Infections (3) · Virus Diseases (3) · COVID-19 (1) · Cystitis (1) · Cystitis, Hemorrhagic (1) · Cytomegalovirus Infections (1) · Epstein-Barr Virus Infections (1) · Hematologic Neoplasms (1) · Pneumonia (1) · Signs and Symptoms, Respiratory (1)
Standard of Care (1)
South Korea (3)
Dong-Gun Lee, MD-PhD (2) · Eun Sun Yoo, MD-PhD (1) · Ho-joon Im, MD-PhD (1) · Hoon Kook, MD-PhD (1) · Hyeon Jin Park, MD-PhD (1) · Hyoung Jin Kang, MD-PhD (1) · Jae-Cheol Jo, MD-PhD (1) · Joonho Moon, MD-PhD (1) · Seung Min Hahn, MD-PhD (1) · Yae-Jean Kim, MD-PhD (1)